1980
DOI: 10.1056/nejm198005013021801
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of Crohn's Disease with 6-Mercaptopurine

Abstract: To test the effectiveness of 6-mercaptopurine (6-MP) in the treatment of Crohn's disease, we entered 83 chronically ill patients into a two-year double-blind study comparing 6-MP with placebo. Crossover data showed that improvement occurred in 26 of 39 courses of 6-MP (67%) as compared with three of 39 courses of placebo (8%) (P less than 0.001). Non-crossover data likewise confirmed the superiority of 6-MP. The drug was more effective than placebo in closing fistulas (31 vs 6%) and in permitting discontinuati… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

6
128
1
4

Year Published

1983
1983
2008
2008

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 959 publications
(139 citation statements)
references
References 20 publications
6
128
1
4
Order By: Relevance
“…This co ntrasts, however, with the use of prednisone and 6-mercaptopurine where the mean onset of response is longer and the relapse rate following withdrawal is not as high as th at seen with cyclosporinc (45). lt is in teresting to note chat, in rhe present study as well as in earlier reports, corticosteroids were aggressively mpere~ o r discontinued following the cyclosporine response.…”
Section: In This Issue Of the Canadian ]Omnal Of Gascroentcrolog:vsupporting
confidence: 46%
“…This co ntrasts, however, with the use of prednisone and 6-mercaptopurine where the mean onset of response is longer and the relapse rate following withdrawal is not as high as th at seen with cyclosporinc (45). lt is in teresting to note chat, in rhe present study as well as in earlier reports, corticosteroids were aggressively mpere~ o r discontinued following the cyclosporine response.…”
Section: In This Issue Of the Canadian ]Omnal Of Gascroentcrolog:vsupporting
confidence: 46%
“…Even the use of clinical severity indices has not provided completely satisfactory methods for diagnostic and management studies in these patients (3)(4)(5)(6)(7). The development of a sensitive and reliable marker of intestinal mucosal disease would be important and useful.…”
Section: Introductionmentioning
confidence: 99%
“…Azathioprine is commonly used as an immunosuppressive agent for organ transplant patients and people suffering from chronic inflammatory diseases including ulcerative colitis and Crohn syndrome (4,5). After oral administration and absorption, ϳ90% of the prodrug azathioprine is converted to 6-mercaptopurine from attack by sulfhydryl-containing compounds such as glutathione and cysteine (6,7).…”
mentioning
confidence: 99%